Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18" [Vaccine 35 (2017) 4828-4835]
Vaccine. 2018 May 3;36(19):2740-2741.
doi: 10.1016/j.vaccine.2017.12.039.
Epub 2017 Dec 20.
1 European Center for Disease Prevention and Control (ECDC), Stockholm, Sweden. Electronic address: angeliki.melidou@ecdc.europa.eu.
2 European Center for Disease Prevention and Control (ECDC), Stockholm, Sweden.
3 European Centre for Disease Prevention and Control, Sweden.
4 WHO Regional Office for Europe, Denmark.
5 Centre of Virology, Vienna, Austria.
6 Scientific Institute of Public Health, Operational Directorate of Communicable and Infectious Diseases, Viral Diseases, Brussels, Belgium.
7 Scientific Institute of Public Health, Operational Directorate of Public Health and Surveillance, Epidemiology of Infectious Diseases, Brussels, Belgium.
8 National Institute of Public Health, Prague, Czech Republic.
9 National Influenza Centre, Statens Serum Institut, Copenhagen, Denmark.
10 National Influenza Centre, Statens Serum Institut, Copenhagen, Denmark; Department of Infectious Diseases and Centre for Global Health, Clinical Institute, University of Southern Denmark, Odense, Denmark.
11 Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
12 National Influenza Centre, Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France.
13 University of Corsica, Corsica, France.
14 Laboratoire de Virologie, National Influenza Centre, IAI, Groupement Hospitalier Nord des HCl, Lyon, France.
15 National Reference, Centre for Influenza, Division Influenza and other Respiratory viruses, Robert Koch Institut, Berlin, Germany.
16 Department for Infectious Disease Epidemiology, Robert Koch Institute, Germany.
17 National Influenza Reference Laboratory of Southern Greece Hellenic Pasteur Institute, Greece.
18 National Influenza Centre for Northern Greece, Microbiology Department, Medical School, Aristotle University of Thessaloniki, Greece.
19 National Virus Reference Laboratory, University College Dublin, Ireland.
20 HSE-Health Protection Surveillance Centre, Ireland.
21 Irish College of General Practitioners, Ireland.
22 Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
23 Ministry of Health, Rome, Italy.
24 Ministry of Health, Bishkek, Kyrgyzstan.
25 Riga East University Hospital, Latvian Centre of Infectious Diseases, National Microbiology Reference Laboratory, Riga, Latvia.
26 Centre for Disease Prevention and Control of Latvia, Riga, Latvia.
27 Laboratoire National de Santé, Dudelange, Luxembourg.
28 Centre for Infectious Diseases Research, Diagnostics and Screening, National Influenza Centre, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
29 Centre for Infectious Diseases Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
30 Department of Viroscience, National Influenza Centre, Erasmus Medical Centre, Rotterdam, Netherlands.
31 NIVEL, Netherlands Institute for Health Services Research, Utrecht, Netherlands.
32 Norwegian institute of Public Health, Oslo, Norway.
33 National Influenza and Other Respiratory Virus Reference Laboratory, Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
34 Department of Epidemiology, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
35 National Institute for Research "Cantacuzino", Bucharest, Romania.
36 FSBI "N.F. Gamaleya FRCEM", National Influenza Centre, Moscow, Russian Federation.
37 Úrad verejného zdravotníctva Slovenskej Republiky, Bratislava, Slovakia.
38 Laboratory for Public Health Virology, National Laboratory for Health Environment and Food, Slovenia.
39 National Centre of Microbiology, Carlos III Health Institute, Madrid, Spain.
40 National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.
41 Hospital Clinico Universitario, National Influenza Centre, Valladolid, Spain.
42 The Public Health Agency of Sweden, Solna, Sweden.
43 University Hospitals of Geneva, Geneva, Switzerland.
44 Federal Office of Public Health, Berne, Geneva, Switzerland.
45 PHE, London, United Kingdom.
46 West of Scotland Specialist Virology Centre, Glasgow, United Kingdom.
47 HPS, Glasgow, United Kingdom.
48 Regional Virus Laboratory, Belfast, United Kingdom.